ArticleFrontiers in oncology2025

First-line immune checkpoint inhibitors combined with chemotherapy in advanced large-cell neuroendocrine carcinoma of the lung: a real-world retrospective study.

Beibei Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.